Disruption of Hepatic Insulin Signaling Causes Phospholipid Dysregulation in Mice
The FASEB Journal · 28.02.2026 · 40 (4)
DOI: 10.1096/fj.202504306r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 24.02.2026. Verfasst von Quan Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: Liver, Insulin, Signal Transduction, Phospholipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funds from the National Institutes of Health (NIH), Texas A&M University, U.S. Department of Agriculture (USDA).
Abstract (Originalsprache)
Phospholipids are important components of the bilayer of biological membranes. Alterations of phospholipids are associated with metabolic disorders, including insulin resistance. However, how impaired insulin signaling impacts phospholipids has not been well established. Disruption of hepatic insulin signaling is achieved by insulin receptor substrate 1 (IRS1) and IRS2 double deletion (DKO) in the liver. Further deletion of TGF‐β1 or Foxo1 in the liver of DKO mice was used to examine the role of TGF‐β1 or Foxo1 in contributing to the alterations of phospholipid metabolism in DKO mice. Disruption of hepatic insulin signaling led to the dysregulation of phospholipids, including phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), sphingomyelin (SM), cardiolipin (CL), and lysophospholipids in the liver. Mechanistically, disruption of hepatic insulin signaling dysregulated the expression of genes related to phospholipid metabolism. Interestingly, further deletion of Tgfb1 in the liver of DKO mice (TKObeta1) attenuated the alterations of phospholipids and rescued the abnormal expression of genes related to phospholipid metabolism. Moreover, deletion of transcription factor Foxo1 , a key mediator of insulin signaling, achieved similar beneficial effects as Tgfb1 deletion in DKO mice. Our study suggests that insulin signaling plays a crucial role in maintaining phospholipids balance in the liver via TGF‐β1 or Foxo1. Targeting TGF‐β1 or Foxo1 could be promising strategies to combat phospholipids alterations and related metabolic dysfunctions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
- Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center at San Antonio, Texas, USA.
- Department of Medicine, Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Quan Pan
Förderung
- Funds from the National Institutes of Health (NIH)
- Texas A&M University
- U.S. Department of Agriculture (USDA)
- NIA NIH HHS
- American Diabetes Association (ADA)
- Foundation for the National Institutes of Health
- Texas A&M University Health Science Center
Zitieren
APA
Pan, Q., Pan, M., Ai, W., Yang, W., Jiang, W., Han, X., & Guo, S. (2026). Disruption of Hepatic Insulin Signaling Causes Phospholipid Dysregulation in Mice. The FASEB Journal, 40(4). https://doi.org/10.1096/fj.202504306r
Vancouver
Pan Q, Pan M, Ai W, Yang W, Jiang W, Han X, et al. Disruption of Hepatic Insulin Signaling Causes Phospholipid Dysregulation in Mice. The FASEB Journal. 2026;40(4). doi:10.1096/fj.202504306r
BibTeX
@article{Pan2026,
author = {Pan, Quan and Pan, Meixia and Ai, Weiqi and Yang, Wanbao and Jiang, Wen and Han, Xianlin and Guo, Shaodong},
title = {Disruption of Hepatic Insulin Signaling Causes Phospholipid Dysregulation in Mice},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {4},
doi = {10.1096/fj.202504306r}
}
EUVIMED